Opioid receptor types and subtypes: The δ receptor as a model

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 379-401

  Zaki, Paulette A ^a   Bilsky, Edward J ^b   Vanderah, Todd W ^b   Lai, Josephine ^b   Evans, Christopher J ^a   Porreca, Frank ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

G protein coupled receptor; opiate; receptor heterogeneity

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DELTA OPIATE RECEPTOR; ENDORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

DRUG RECEPTOR BINDING; GENE; HUMAN; MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ALTERNATIVE SPLICING; ANALGESICS; ANIMALS; CLONING, MOLECULAR; DOPAMINE; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; MICE; NARCOTIC ANTAGONISTS; PROTEIN BINDING; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0029949928     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (96)

1. Childers SR. 1991. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991-2003
2. North RA. 1993. Opioid action on membrane ion channels. See Ref. 94, pp. 773-93
3. Goldstein A, Naidu A. 1989. Multiple opioid receptors: ligand selectivity profiles and binding signatures. Mol. Pharmacol. 36:265-72
4. 2 opioid receptors. Proc. Natl. Acad. Sci. USA 85:4061-65
5. Paul D, Bodnar RJ, Gistrak MA, Pasternak GW. 1989. Different μ receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur. J. Pharmacol. 168:307-14
6. Sofuoglu M, Portoghese PS, Takemori AE. 1991. Differential antagonism of 6 opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for δ opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257:676-80
7. 2]deltorphin II in mice: evidence for delta receptor sub-types. J. Pharmacol. Exp. Ther. 258:583-87
8. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. 1992. The δ-opioid receptor: isolation of a cDNA clone by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-52
9. Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH. 1992. Cloning of the δ opioid receptor by functional expression. Science 258:1952-55
10. Kieffer BL. 1995. Receptors for opioid peptides. In Recent Advances in Molecular Recognition and Signal Transduction of Active Peptides. In press
11. Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, et al. 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-35
12. Miotto K, Magendzo K, Evans CJ. 1995. Molecular characterization of opioid receptors. In The Pharmacology of Opioid Peptides, ed. L Tseng. Singapore: Harwood Acad.
13. Li X, Keith DE, Evans CJ. 1995. Identification of opioid receptor-like sequences among different species. Soc. Neurosci. Abstr. (3):1843
14. Bare LA, Mansson E, Yang DM. 1994. Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354: 213-16
15. Min BH, Augustin LB, Felsheim RF, Fuchs JA, Loh HH. 1994. Genomic structure analysis of promoter sequence of a mouse μ opioid receptor gene. Proc. Natl. Acad. Sci. USA 91:9081-85
16. Probst WC, Snyder LA, Schuster DI, Brosius J, Seaflon SC. 1992. Sequence alignment of the G-protein-coupled receptor superfamily. DNA Cell Biol. 11: 1-20
17. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR. 1993. μ opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90:10230-34
18. Surratt CK, Johnson PS, Moriwaki A, Seidleck BK, Blaschak CJ, et al. 1994. μ Opiate receptor: Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269:20548-53
19. Kong H, Raynor K, Yasuda K, Moe ST, Portoghese PS, et al. 1993. A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268: 23055-58
20. Claude P, Erickson L, McGinn T, Loh H, Law P. 1995. Single amino acid mutation in transmembrane region confers agonist activity to antagonists. Int. Narcotics Res. Conf. p. 35. (Abstr.)
21. Wotta D, Claude P, Loh H, Law P. 1995. Single point mutation of opioid receptors expressed in Xenopus oocytes imparts antagonists with agonist activity monitored through GIRK1 channel. Int. Narcotics Res. Conf. p. 35. (Abstr.)
22. 6]-enkephalin and 5′-naltrindole isothiocyanate (5′-NTII): evidence for δ receptor subtypes. J. Pharmacol. Exp. Ther. 257: 1069-75
23. Porreca F, Takemori AE, Portoghese PS, Sultana M, Bowen WD, et al. 1992. Modulation of μ-mediated antinociception by a subtype of opioid δ receptor in the mouse. J. Pharmacol. Exp. Ther. 263:147-52
24. Mosberg HI, Hurst R, Hruby VJ, Gee K, Akiyama K, et al. 1983. Cyclic penicillamine containing enkephalin analogs display profound δ receptor selectivities. Life Sci. 33:447-50
25. Kreil G, Barra D, Simmaco M, Erspamer V, Erspamer GF, et al. 1989. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for δ opioid receptors. Eur. J. Pharmacol. 162:123-28
26. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, et al. 1989. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. USA 86:5188-92
27. 2]deltorphin II, a highly selective δ agonist in vivo. Life Sci. Pharmacol. Lett. 47: PL43-PL47
28. 5]enkephalin in the rat. J. Pharmacol. Exp. Ther. 259: 725-31
29. 4]deltorphin. J. Pharmacol. Exp. Ther. 266: 820-28
30. Tiseo PJ, Yaksh TL. 1993. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for δ-opioid receptor subtypes in the rat. Eur. J. Pharmacol. 236:89-96
31. 6]enkephalin: covalent attachment via thiol-disulfide exchange. J. Biol. Chem. 262:13434-39
32. 6]enkephalin (DALES): antinociception actions at the δ non-complexed-opioid receptor. Eur. J. Pharmacol. 192:371-75
33. 6]enkephalin: short-term agonist effects and long-term antagonism at δ opioid receptors. Peptides 10:319-26
34. Portoghese PS, Sultana M, Takemori AE. 1990. Naltrindole 5′-isothiocyanate: a nonequilibrium, highly selective δ opioid receptor antagonist. J. Med. Chem. 33:1547-48
35. 2 receptors. J. Pharmacol. Exp. Ther. 267:449-55
36. Takemori AE, Portoghese PS. 1992. Selective naltrexone-derived opioid receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32:239-69
37. Portoghese PS, Nagase H, MaloneyHuss KE, Lin C-E, Takemori AE. 1991. Role of spacer and address components in peptidomimetic δ opioid receptor antagonists related to naltrindole. J. Med. Chem. 34:1715-20
38. 1 opioid receptor antagonist: 7-benzylidenenaltrexone. Eur. J. Pharmacol. 218:195-96
39. 1 opioid receptor antagonist in the mouse spinal cord. Life Sci. 52:769-75
40. Sofuoglu M, Portoghese PS, Takemori AE. 1991. Cross-tolerance studies in the spinal cord of beta-FNA-treated mice provides further evidence for δ opioid receptor subtypes. Life Sci. Pharmacol. Lett. 49:PL153-56
41. Stewart PE, Hammond DL. 1994. Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J. Pharmacol. Exp. Ther. 268:701-8
42. Malmberg AB, Yaksh TL. 1992. Isobolographic and dose-response analyses of the interaction between intrathecal μ and δ agonists: effects of naltrindole and its benzofuran analog (NTB). J. Pharmacol. Exp. Ther. 263:264-75
43. 2- and μ-opioid receptor agonists on excitatory transmission in lamina-II neurons of adult-rat spinal-cord. J. Neurosci. 14: 4965-71
44. Ossipov MH, Kovelowski CJ, Nichols ML, Hruby VJ, Porreca F. 1995. Characterization of supraspinal antinociceptive actions of opioid δ agonists in the rat. Pain 62:287-93
45. Vaught JL, Takemori AE. 1979. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208:86-90
46. Lee NM, Leybin L, Chang JK, Loh HH. 1980. Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur. J. Pharmacol. 68:181-85
47. Heyman JS, Mulvaney SA, Mosberg HI, Porreca F. 1986. Evidence for μ-δ interactions in vivo. Soc. Neurosci. Abstr. 12:1014
48. 5]enkephalin. Eur. J. Pharmacol. 165:1-10
49. Heyman JS, Jiang Q, Rothman RB, Mosberg HI, Porreca F. 1989. Modulation of μ-mediated antinociception by δ agonists: characterization with antagonists. Eur. J. Pharmacol. 169:43-52
50. Rothman RB, Holaday JW, Porreca F. 1993. Allosteric coupling among opioid receptors: evidence for an opioid receptor complex. See Ref. 94, pp. 217-37
51. Rossi GC, Pasternak GW, Bodnar RJ. 1994. μ and δ opioid synergy between the periaqueductal gray and the rostroventral medulla. Brain Res. 665:85-93
52. Rossi GC, Pasternak GW, Bodnar RJ. 1993. Synergistic brainstem interaction for morphine analgesia. Brain Res. 624: 171-80
53. 4]deltorphin with δ-opioid receptor subtypes in vivo. Eur. J. Pharmacol. 252:133-37
54. Buzas B, Izenwasser S, Portoghese PS, Cox BM. 1994. Evidence for δ opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sci. 54:PL101-6
55. 2-opioid agonists in rat caudate putamen. J. Neurochem. 65:125-33
56. Crook TJ, Kitchen I, Hill RG. 1992. Effects of the δ-opioid receptor antagonist naltrindole on antinociceptive responses to selective δ agonists in post-weanling rats. Br. J. Pharmacol. 107: 573-36
57. Crook TJ, Kitchen I, Hill RG. 1993. Differential antagonism of the antinociceptive effects of selective δ-opioid receptor agonists by the δ-antagonist naltriben in post-weanling rats. Pharmacol. Commun. 3:351-56
58. Kitchen I, Crook TJ, Muhammad BY. Hill RG. 1994. Evidence that weanling stimulates the developmental expression of the δ-opioid receptor subtype in the rat. Dev. Brain Res. 78:147-50
59. Kitchen I, Leslie FM, Kelly M, Barnes R, Crook TJ, et al. 1995. Development of δ-opioid receptor subtypes and regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies. J. Pharmacol. Exp. Ther. In press
60. Negri L, Potenza RL, Corsi R, Melchiorri P. 1991. Evidence for two subtypes of δ opioid receptors in rat brain. Eur. J. Pharmacol. 196:335-36
61. Vaughn LK, Wire WS, Davis P, Shimohigashi Y, Toth G, et al. 1990. Differentiation between rat brain and mouse vas deferens δ opioid receptors. Eur. J. Pharmacol. 177:99-101
62. 4-enkephalin analogs. δ receptors in rat brain are different from those in mouse vas deferens. Fed. Eur. Biochem. Soc. 222:71-74
63. 3H]naltrindole binding to δ opioid receptors in mouse brain and mouse vas deferens: evidence for δ opioid receptor heterogeneity. J. Pharmacol. Exp. Ther. 268:836-46
64. 3H]naltrindole binding to δ opioid receptors in rat brain. Life Sci. 50:PL119-24
65. Xu H, Partilla JS, de Costa BR, Rice KC, Rothman RB. 1992. Interaction of opioid peptides and other drugs with multiple δ-ncx binding sites in rat brain: further evidence for heterogeneity. Peptides 13:1207-13
66. Xu H, Ni Q, Jacobson AE, Rice KC, Rothman RB. 1991. Preliminary ligand binding data for subtypes of the δ opioid receptor in rat brain membranes. Life Sci. Pharmacol. Lett. 49:PL141-46
67. ncx binding sites in mouse brain: further evidence for δ receptor heterogeneity. Peptides 14:893-907
68. ncx opioid binding sites in vitro and in vivo. Peptides 13:691-94
69. Vaught JL, Rothman RB, Westfall TC. 1982. μ and δ receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci. 30:1443-55
70. Schoffelmeer ANM, Rice KC, Jacobson AE, Van Gelderen JG, Hogenenboom F, et al. 1988. μ-, δ- and κ-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur. J. Pharmacol. 154:169-78
71. Cha XY, Xu H, Rice KC, Porreca F, Lai J, et al. 1995. Opioid peptide receptor studies. 2. Identification of a novel δ opioid receptor binding site in rat brain membranes. Peptides 16:191-98
72. Wahlestedt C, Golanov E, Yamamoto S, Yee F, Ericson H, et al. 1993. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363:260-63
73. 1 receptors by antisense oligodeoxynucleotides. Science 259:528-31
74. Wahlestedt C. 1994. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15:42-46
75. 4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid δ receptor. Life Sci. 55:PL37-PL43
76. 2-agonist antinociception. NeuroReport 5:1049-52
77. Standifer KM, Chien C-C, Wahlestedt C, Brown GP, Pasternak GW. 1994. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12:805-10
78. Tseng L, Collins KA, Kampine JP. 1994. Antisense oligodeoxynucleotide to a δ opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258:R1-R3
79. Mattia A, Farmer SC, Takemori AE, Sultana M, Portoghese PS, et al. 1992. Spinal opioid δ antinociception in the mouse: mediation by a 5′-NTII-sensitive δ receptor subtype. J. Pharmacol. Exp. Ther. 260:518-25
80. Bilsky EJ, Bernstein RN, Hruby VJ, Rothman RB, Lai J, Porreca F 1995. Characterization of antinociception to opioid receptor selective agonists following antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptors in vivo. J. Pharmacol. Exp. Ther. In press
81. Lai J, Payne A, Porreca F. 1995. Antisense oligodeoxynucleotide-mediated reduction of δ opioid receptors in NG 108-15 cells: direct correlation between antisense uptake and receptor "knock-down". Int. Narcotics Res. Conf. p. 19. (Abstr.)
82. Heagy W, Finberg R, Teng E, McAllen K, Sharp B. 1995. Opiate receptors and signaling in lymphocytes. Symp. Aids Drugs of Abuse Neuroimmune Axis, p. 10 (Abstr.)
83. Xie G, Miyajima A, Goldstein A. 1992. Expression cloning of a cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. Proc. Natl. Acad. Sci. USA 89:4124-28
84. 2]deltorphin-I. Synapse 13: 231-40
85. Mansour A, Fox CA, Akil H, Watson SJ. 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:22-29
86. Halford WP, Gebhardt BM, Carr DJ. 1995. Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J. Neuroimmunol. 5:91-101
87. Zimprich A, Simon T, Hollt V. 1995. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist-induced desensitization from rMOR1. FEBS Lett. 359: 142-46
88. Chen Y, Mestek A, Liu J, Hurley JA, Yu L. 1993. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:8-12
89. Schulz S, Schreff M, Zimprich A, Hollt V. 1995. Differential expression of the μ-opioid receptor isoforms rMOR1 and rMOR1B in rat brain. Int. Narcotics Res. Conf. p.2. (Abstr.)
90. Mouillac B, Caron M, Bonin H, Dennis M, Bouvier M. 1992. Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. J. Biol. Chem. 267:21733-37
91. Costa T, Lang J, Gless C, Herz A. 1990. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions. Mol. Pharmacol. 37:383-94
92. Prather P, McGinn T, Erickson L, Evans C, Loh H, Law P. 1994. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J. Biol. Chem. 269: 21293-302
93. Cruciani R, Dvorkin B, Morris S, Crain S, Makman M. 1993. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA 90:3019-23
94. Tsu RC, Chan JSC, Wong YH. 1995. Regulation of multiple effectors by the cloned δ-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. J. Neurochem. 64:2700-7
95. Lefkowitz RJ, Inglese J, Koch WJ, Pitcher J, Attramadal H, Caron MG. 1992. G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins. Cold Spring Harbor Symp. Quant. Biol. 57:127-33
96. Herz A, ed. 1993. Handbook of Experimental Pharmacology, Opioids I. Vols. 1, 2. Berlin: Springer-Verlag. 815 pp. 840 pp.